Spotlight commentary: Changes in pharmacokinetics following significant weight loss
| Author | Belančić, Andrej |
| Author | Al-Sallami, Hesham S. |
| Available date | 2025-04-23T12:24:48Z |
| Publication Date | 2025-03 |
| Publication Name | British Journal of Clinical Pharmacology |
| Identifier | http://dx.doi.org/10.1111/bcp.16401 |
| Citation | Belančić, A., & Al‐Sallami, H. S. (2025). Spotlight commentary: Changes in pharmacokinetics following significant weight loss. British Journal of Clinical Pharmacology, 91(3), 678. |
| ISSN | 0306-5251 |
| Abstract | Obesity is associated with detrimental metabolic, mechanical and psy-chological outcomes, leading to diminished qualify of life and reducedlifespan. Whilst lifestyle modifications, including diet and physicalactivity, remain essential for managing obesity management, manypatients with obesity require additional interventions for effectivetreatment. These include anti-obesity medicines (e.g., GLP-1 receptoragonists) and/or bariatric surgery. |
| Sponsor | Open access publishing facilitated by University of Otago, as part of the Wiley - University of Otago agreement via the Council of Australian University Librarians. |
| Language | en |
| Publisher | John Wiley and Sons Inc |
| Subject | bariatric surgery drug dosage GLP-1 receptor agonists obesity pharmacokinetics weight loss |
| Type | Article |
| Issue Number | 3 |
| Volume Number | 91 |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Research [1384 items ]